We are live on ! Find out more
CLPT icon

ClearPoint Neuro

89 hedge funds and large institutions have $117M invested in ClearPoint Neuro in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,361% more call options, than puts

Call options by funds: $7.09M | Put options by funds: $485K

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

53% more capital invested

Capital invested by funds: $76.5M → $117M (+$40.5M)

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

14% more funds holding

Funds holding: 7889 (+11)

2.84% more ownership

Funds ownership: 24.73%27.56% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
89
Holders Change
+11
Holders Change %
+14.1%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
24
Reduced
18
Closed
11
Calls
$7.09M
Puts
$485K
Net Calls
+$6.6M
Net Calls Change
+$6.28M
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$1.03M
Barclays
27
Barclays
United Kingdom
$1.02M +$787K +60,762 +1,071%
CSS
28
Cubist Systematic Strategies
Connecticut
$1.01M +$160K +12,372 +23%
BFS
29
Bradley Foster & Sargent
Connecticut
$871K +$734K +56,663 New
6CM
30
683 Capital Management
New York
$836K +$704K +54,387 New
Northern Trust
31
Northern Trust
Illinois
$824K -$18.1K -1,394 -3%
NA
32
Navellier & Associates
Nevada
$769K
PHS
33
Pekin Hardy Strauss
Illinois
$742K
EI
34
EAM Investors
California
$739K -$401K -30,958 -39%
UBS Group
35
UBS Group
Switzerland
$710K +$197K +15,213 +49%
Bank of America
36
Bank of America
North Carolina
$651K +$372K +28,742 +212%
OAC
37
OMERS Administration Corp
Ontario, Canada
$644K +$543K +41,900 New
Ameriprise
38
Ameriprise
Minnesota
$635K +$35.5K +2,742 +7%
LPL Financial
39
LPL Financial
California
$619K +$22.7K +1,750 +5%
SAM
40
Silvercrest Asset Management
New York
$549K
Citigroup
41
Citigroup
New York
$431K -$810K -62,519 -69%
PAS
42
Point72 Asia (Singapore)
Singapore
$416K -$26.9K -2,075 -7%
GCP
43
GSA Capital Partners
United Kingdom
$397K +$335K +25,833 New
Citadel Advisors
44
Citadel Advisors
Florida
$387K -$787K -60,736 -71%
Lazard Asset Management
45
Lazard Asset Management
New York
$355K +$122K +9,433 +69%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$329K -$146K -11,265 -34%
NA
47
NewEdge Advisors
Louisiana
$325K +$18.5K +1,431 +7%
VF
48
Virtu Financial
New York
$316K +$267K +20,576 New
T. Rowe Price Associates
49
T. Rowe Price Associates
Maryland
$273K
ACM
50
Aster Capital Management
United Arab Emirates
$269K

CLPT Hedge Fund Activity: Q4 2024 in Review

89 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2024, worth a combined $117M — up 53% from $76.5M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CLPT positions and 11 closed out — a net gain of 11 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $4.64M. The largest seller was Marshall Wace, cutting an estimated $3.42M.

  • 89 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2024, up from 78 in Q3 2024.
  • Funds reported $117M of ClearPoint Neuro stock for Q4 2024, up 53% quarter-over-quarter.
  • 22 funds opened new ClearPoint Neuro positions in Q4 2024 and 11 closed out, a net change of +11 holders.
  • The largest ClearPoint Neuro buyer in Q4 2024 was Susquehanna International Group, an estimated $4.64M added.
  • The largest ClearPoint Neuro seller in Q4 2024 was Marshall Wace, an estimated $3.42M sold.

Based on aggregated 13F filings for Q4 2024.